EDARBI 80mg price in UAE

Overview

Welcome to Dwaey, specifically on EDARBI 80mg Tablets page.
This medicine contains an important and useful components, as it consists of Azilsartan medoxomil (as potassium).
EDARBI 80mg is available in the market in concentration 80mg/Tablet and in the form of Tablets.

TAKEDA PHARMACEUTICALS U.S.A., INC. is the producer of EDARBI 80mg and it is imported from USA, The most popular alternatives of EDARBI 80mg are listed downward .

Mode Of Action

Angiotensin II blocker; displaces angiotensin II from AT1 receptor and may lower blood pressure by antagonizing AT1-induced vasoconstriction, aldosterone release, catecholamine release, arginine vasopressin release, water absorption, and hypertrophic responses. May induce more complete inhibition of renin-angiotensin system compared with ACE inhibitors; does not affect response to bradykinin. Inhibits the pressor effects of an angiotensin II infusion in a dose-related manner.

Indication

Treatment of Hypertension
alone or in combination w/ other antihypertensive agents.

Precaution

Correct vol or salt depletion prior to administration. Renal (moderate to severe) & hepatic (severe) impairment. Pregnancy (1st trimester) & lactation. Childn <18 yr. Monitor serum K in patients taking K-sparing diuretics, salt substitutes containing K & drugs that increase K levels (eg heparin) & creatinine levels in patients w/ renal impairment & type 2 DM. Aortic or mitral valve stenosis, hypertrophic obstructive cardiomyopathy. Lactation: unknown whether distributed in breast milk, decide on alternate antihypertensive therapy or do not breastfeed

Side Effects

1-10% Diarrhea (2%) <1% Nausea
Asthenia
Fatigue
Muscle spasm
Dizziness
Postural hypotension
Cough

Contra indication

Hypersensitivity. Pregnancy.

Pregnancy and lactation

Pregnancy category: D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Pregnancy Category: C (1st trimester); D (2nd and 3rd trimesters)

Interaction

Reversibly increases serum conc & toxicity of lithium; attenuated antihypertensive effects & risk of worsening of renal function may occur w/ NSAIDs. Hyperkalemia w/ K-sparing diuretics & K supplements.